title: Interleukin 2 levels and urine cytology distinguish between cyclosporine toxicity and rejection in renal and liver allograft recipients.
authors.affiliation: Department of Surgery, Harvard Medical School, New England Deaconess Hospital, Boston, MA 02215.
authors.forename: A
authors.initials: A
authors.lastname: Cornaby
authors.forename: M
authors.initials: M
authors.lastname: Simpson
authors.forename: R
authors.initials: R
authors.lastname: Vann Rice
authors.forename: R
authors.initials: R
authors.lastname: Dempsey
authors.forename: P
authors.initials: P
authors.lastname: Madras
authors.forename: R
authors.initials: R
authors.lastname: Jenkins
authors.forename: A
authors.initials: A
authors.lastname: Monaco
mesh_terms: D003524:Cyclosporins / Q000633:toxicity*; D003937:Diagnosis, Differential; D006084:Graft Rejection; D006801:Humans; D007376:Interleukin-2 / Q000097:blood* / Q000652:urine*; D007674:Kidney Diseases / Q000175:diagnosis / Q000473:pathology; D016030:Kidney Transplantation; D016031:Liver Transplantation; D014556:Urine / Q000473:pathology
chemical_list: D003524:Cyclosporins; D007376:Interleukin-2